Skip to content

Screener

Eligibility screening

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Sponsored by NiKang Therapeutics, Inc.Study detailsClinicalTrials.gov

19 US sites in AR, CA, CO, FL +9

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.